In summary, our results offer novel evidence that endothelial Sphk1/S1P signaling regulates brain injury in the context of ischemic stroke in an eNOS‐ and NO‐dependent manner, suggesting that targeting this signaling axis may represent a viable therapeutic strategy for future treatment efforts. The gene discussed is MBTPS1; the disease is ischemic stroke.